Search results
Results from the WOW.Com Content Network
[7] Research also supports that atypical depression tends to have an earlier onset, with teenagers and young adults more likely to exhibit atypical depression than older patients. [2] Patients with atypical depression have shown to have higher rates of neglect and abuse in their childhood as well as alcohol and drug disorders in their family. [10]
Usually, the atypical causes also involve atypical symptoms: No response to common antibiotics such as sulfonamide [5] and beta-lactams like penicillin.; No signs and symptoms of lobar consolidation, [6] [7] meaning that the infection is restricted to small areas, rather than involving a whole lobe.
Mycobacterium avium-intracellulare infection (MAI) is an atypical mycobacterial infection, i.e. one with nontuberculous mycobacteria or NTM, caused by Mycobacterium avium complex (MAC), which is made of two Mycobacterium species, M. avium and M. intracellulare. [1]
Atypia of undetermined significance (AUS) or follicular lesion of undetermined significance (FLUS) (follicular or lymphoid cells with atypical features) 5–15%: Repeating FNAC IV Follicular nodule/suspicious follicular nodule (cell crowding, micro follicles, dispersed isolated cells, scant colloid) 15–30%: Surgical lobectomy V
Atypical trigeminal neuralgia (ATN), or type 2 trigeminal neuralgia, is a form of trigeminal neuralgia, a disorder of the fifth cranial nerve. This form of nerve pain is difficult to diagnose, as it is rare and the symptoms overlap with several other disorders. [ 1 ]
Marked atypia of type 2 pneumocytes is a characteristic finding in association with treatment with busulfan and other chemotherapeutic agents.. Atypia (from Greek, a + typos, without type; a condition of being irregular or nonstandard) [1] is a histopathologic term for a structural abnormality in a cell, i.e. it is used to describe atypical cells.
Lumateperone, sold under the brand name Caplyta, is an atypical antipsychotic medication of the butyrophenone class. It is approved for the treatment of schizophrenia as well as bipolar depression, as either monotherapy or adjunctive therapy (with lithium or valproate). [2] It is developed by Intra-Cellular Therapies, licensed from Bristol ...
Clinical signs and symptoms of complement-mediated TMA can include abdominal pain, [9] confusion, [9] fatigue, [5] edema (swelling), [10] nausea/vomiting [11] and diarrhea. [12] aHUS often presents with malaise and fatigue, as well as microangiopathic anemia. [8]: 1931 However, severe abdominal pain and bloody diarrhea are unusual.